GCT Awarded a Rare Genetic Epilepsy Study in Pediatric Patients
A new Neurology Study has been awarded to Global Clinical Trials. It is a trial for children living with a rare epilepsy syndrome characterized by seizures and cognitive delays. The condition is due to a mutation of a gene on the X chromosome.
This study will be managed at several Russian sites by GCT. We will perform a wide scope of services including all the activities associated with the project management, monitoring and logistics. Presently, the trial is in the active start-up phase. We look forward to reaching the first study milestone.
Updated: March 23, 2020